Home > Node > Subnode Tiagabine Pierce, M.W.; Suzdak, P.D.; Gustavson, L.E.; Mengel, H.B.; McKelvy, J.F.; Mant, T. Epilepsy Research. Supplement 3: 157-1601991ISSN/ISBN: 0922-9833 PMID: 1777074 Document Number: 379465 Document emailed within 1 workday Purchase for $29.90 Secure & encrypted paymentsRelated Documents 1998: Tiagabine for epilepsy Medical Letter on Drugs and Therapeutics 40(1024): 45-46Jedrzejczak, J. 2000: Evaluation of tiagabine efficacy in different groups of patients with epilepsy Neurologia i Neurochirurgia Polska 34(Suppl 7): 9-16Pakulska, W. 2007: Influence of tiagabine on the antinociceptive action of morphine, metamizole and indomethacin in mice Acta Poloniae Pharmaceutica 64(3): 263-270Chmielewska, B.; Stelmasiak, Z. 2008: GABI-balance--a non-interventional observational study on the effectiveness of tiagabine in add-on therapy in partial epilepsy Neurologia i Neurochirurgia Polska 42(4): 303-311Halczuk, I.; Lipa, A.; Mitosek-Szewczyk, K.; Sobolewski, P.; Stelmasiak, Z.; Kaczyński, K. 2015: Evaluation of the effectiveness of add-on therapy with tiagabine and evaluation of cognitive functions after application of this therapy in patients with drug-resistant focal epilepsy - an observational study (GABI-EPI) Wiadomosci Lekarskie 68(4 Part 2): 680-689